A program was presented that would seek to bring medicines home
The goal is to serve people with chronic, autoimmune conditions or who require injectable medication
In Mexico, the pharmaceutical market generates sales of more than 10 billion dollars
The purchase and distribution of medicines is often complicated, especially due to the existing regulation in this market. However, pharmaceutical companies are designing a program that aims to bring medicines to the doors of patients’ homes in Mexico.
An initiative that arises in the context of the impact on the health sector and the difficulties that the population has faced as a result of the virus mitigation measures and the limitations of social mobility.
Awaiting authorization
The objective would be to serve a group of people who suffer from chronic, autoimmune conditions or who require injectable medication and who, for various reasons, require receiving their medications at home.
According to Cristobal Thompson, executive director of the Mexican Association of Pharmaceutical Research Industries (AMIIF), in total there are 12 pharmaceutical laboratories that are part of this initiative, which have a list of 70 medications that help fight these conditions.
« The impact on health, mental health, economic, is being very complicated globally and we were not clear about the secondary impact and how it would affect the follow-up of patients with non-communicable diseases, » he said in a virtual press conference, quoted by the . agency, a report released by La Vanguardia.
The information available indicates that among the pharmaceutical companies that are part of the program, Roche and Takeda and, according to Thompson, referred to in El Universal, the laboratories would absorb the cost of bringing the treatment home, as well as the responsibility of providing training to patients to self-administer the medications.
It may interest you:
A problem, an opportunity
It is a situation that has become a challenge for many countries. According to the World Health Organization (WHO), noncommunicable disease services and treatments have been affected since the pandemic began.
In this regard, a survey conducted by the agency in 155 countries, reveals that the 53 percent people report that they totally or partially interrupted hypertension treatments; 49 percent of diabetes; 42 percent Of cancer; and 31 percent cardiovascular diseases.
In this sense, it is pertinent to note that the pharmaceutical market represents sales of approximately 916 million units -or products- (2017), according to IQVIA data, while in 2018, it represented more than $ 10.4 billion, according to data from BMI Research.
SUBSCRIBE TO PREMIUM CONTENT FOR JUST $ 299
